China Bioventures' Role In Virus Fight Helps Secure $721m In New Funding, Deals
But Some Caution Remains
Developing some of the first coronavirus vaccines and antibody testing kits, venture-backed firms in China have responded fast and partnered actively in the fight against the pandemic, helping them to raise new funds and reach deals. But there have been cautionary tales in other sectors and some investors remain wary.
